K., & Jeukendrup, A
Smits MM, van Raalte DH, Tonneijck L, Muskiet MHA, Kramer MHH, Cahen DL
A 2025 study presented at the Endocrine Societys annual meeting found that men with obesity or type 2 diabetes who used GLP-1 medications saw both significant weight loss and improved testosterone levels
By addressing the hormonal and behavioral drivers of obesity, the program gives patients effective tools to reduce weight safely and with greater confidence
Autistic symptom changes were not evaluated as part of the study, but children in both groups showed improvement in cysteine, plasma sulfate, and whole-blood glutathione levels
This blog explains why they work well together, what science says about safety, and how to use them responsibly